[
  {
    "criterion": "Reward for accurately documenting the current antihypertensive and lipid-lowering medications with exact names (losartan, atorvastatin), dosages (50 mg daily, 10 mg nightly), duration on therapy (\u22481 month for losartan), patient-reported adherence, and explicit absence of expected side-effects (no cough on losartan, no muscle aches on atorvastatin)",
    "weight": 25,
    "sense": "positive"
  },
  {
    "criterion": "Reward for capturing home blood-pressure monitoring details, including typical in-range readings, the single stress-related elevated value, and the clinician\u2019s instruction to report any persistent elevations",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for including patient-education counseling given during the visit\u2014continue regular BP checks, take atorvastatin at night, and secure adequate medication supply before travel/refills",
    "weight": 15,
    "sense": "positive"
  },
  {
    "criterion": "Reward for specifying an evidence-based safety/monitoring plan (e.g., ordering or confirming recent renal function and potassium labs within 4\u20136 weeks of losartan start and a lipid panel for statin efficacy) or clearly documenting why such monitoring is not needed",
    "weight": 15,
    "sense": "positive"
  },
  {
    "criterion": "Penalize for inclusion of redundant or copy-pasted chart information not newly addressed in the encounter (e.g., full past history or medication list repeated without updates)",
    "weight": 10,
    "sense": "negative"
  },
  {
    "criterion": "Penalize for failing to document a clear follow-up plan or contingency instructions if BP remains uncontrolled, thereby creating a potential patient-safety gap",
    "weight": 15,
    "sense": "negative"
  }
]